BioCentury | Nov 3, 2014
Company News

AKTivate Therapeutics, Virax deal

...in Phase Ib testing for ovarian cancer. AKTivate has exclusive, worldwide rights to TCN-P from Cahaba Pharmaceuticals...
Items per page:
1 - 1 of 1
BioCentury | Nov 3, 2014
Company News

AKTivate Therapeutics, Virax deal

...in Phase Ib testing for ovarian cancer. AKTivate has exclusive, worldwide rights to TCN-P from Cahaba Pharmaceuticals...
Items per page:
1 - 1 of 1